According to the latest report by IMARC Group, titled “Europe Implantable Medical Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the Europe implantable medical devices market size reached US$ 33.1 Billion in 2022. Implantable medical devices are advanced, biocompatible instruments designed for placement inside the human body, where they function continuously to rectify, augment, or replace the functions of certain biological structures. These devices range from commonly used pacemakers, stents, and artificial joints to innovative devices like neurostimulators and drug infusion pumps. Additionally, they help monitor and control bodily functions, manage pain, or treat conditions like heart disease, diabetes, orthopedic problems, and neurological disorders. Furthermore, recent advances in microfabrication technology have enabled the development of highly sophisticated, miniaturized devices that can be implanted with minimally invasive procedures. Given their substantial impact on patients' quality of life and the potential to mitigate healthcare costs, implantable medical devices have garnered significant attention in the global healthcare industry.
Europe Implantable Medical Devices Market Trends:
The Europe implantable medical devices market has been witnessing substantial growth over the years. One of the key market drivers is the aging population, coupled with a rise in chronic diseases like cardiovascular ailments, neurological disorders, and orthopedic conditions, which have significantly contributed to the escalating demand for implantable medical devices. Moreover, technological advancements leading to the development of high-precision, minimally invasive devices have catalyzed the market growth. Additionally, the presence of robust healthcare infrastructure and increased healthcare expenditure by governments and private entities have further stimulated the market. On the other hand, a rise in health and wellness consciousness has led to an increase in preventive healthcare practices, contributing to the market growth. In addition to this, there is an increasing adoption of innovative devices that enable remote patient monitoring, predictive analytics, and personalized care. Alongside, the growing emphasis on patient safety has stimulated the development of bioresorbable implants, minimizing post-operative complications and reducing the need for removal surgeries. Moreover, a surge in strategic collaborations and partnerships between market players to advance research and product development has been observed. Lastly, the rise in preference for home healthcare and outpatient settings for implant surgeries is anticipated to sustain the market growth in the foreseeable future. Looking forward, the market value is projected to reach US$ 48.3 Billion by 2028, expanding at a CAGR of 6.3% during 2023-2028.
- Based on the product, the market has been segmented into orthopedic implants, dental implants, facial implants, breast implants, cardiovascular implants, and others.
- On the basis of the material, the market has been divided into polymers, metals, ceramics, and biologics.
- Based on the end user, the market has been segregated as hospitals, ambulatory surgery centers (ASCs), and clinics.
- Region-wise, the market has been segmented into Germany, France, United Kingdom, Italy, Spain, and Others.
- The competitive landscape of the market has also been examined, along with the profiles of the key players.
|Base Year of the Analysis
||Product, Material, End User, Country
||Germany, France, United Kingdom, Italy, Spain, Others
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800